文献速递先天性心脏病外科

MELD-XI评分预测儿童Fontan患者心脏移植后生存

Hepatorenal dysfunction assessment with the Model for End-Stage Liver Disease Excluding INR score predicts worse survival after heart transplant in pediatric Fontan patients.
PubMed 文献 · J Thorac Cardiovasc Surg · 2021-02-18

本研究基于儿童心脏移植学会数据库,评估MELD-XI评分对儿童Fontan患者心脏移植后死亡风险的预测价值。多变量分析显示,MELD-XI评分(平方)、蛋白丢失性肠病病史和移植时使用心室辅助装置是早期移植后死亡的独立危险因素;

要点

  • MELD-XI评分可识别儿童Fontan患者心脏移植后死亡高风险者。
  • 蛋白丢失性肠病病史和移植时使用心室辅助装置也是危险因素。

核心结论

  • MELD-XI评分易于计算,有助于识别儿童Fontan患者心脏移植后死亡风险增加。

研究设计与样本

  • 565例Fontan患者接受移植,其中524例(93%)在移植时有可计算的MELD-XI评分。

主要发现

  • 多变量分析显示,MELD-XI评分(平方)(风险比1.007)、蛋白丢失性肠病病史(风险比2.1)和移植时使用心室辅助装置(风险比3.4)是早期移植后死亡的独立危险因素。

临床怎么用

  • 临床可使用MELD-XI评分辅助评估儿童Fontan患者心脏移植后死亡风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Fontan physiology results in multiorgan dysfunction, most notably affecting the liver and kidney. We evaluated the utility of Model for End-Stage Liver Disease Excluding INR (MELD-XI) score, a score evaluating the function of both liver and kidney to identify Fontan patients at increased risk for morbidity and mortality post-heart transplant. METHODS: The Pediatric Heart Transplant Society database was queried to identify Fontan patients listed for heart transplant between January 2005 and December 2018. MELD-XI scores were calculated at listing and heart transplant. A multivariable analysis was conducted to identify risk factors for post-heart transplant mortality. Demographic, clinical characteristics, and survival differences were evaluated and compared between the high and low MELD-XI score cohorts. The impact of changing MELD-XI scores during the waitlist period on post-heart transplant outcomes was also evaluated. RESULTS: Of 565 Fontan patients who underwent transplantation, 524 (93%) had calculable MELD-XI scores at the time of heart transplant: 421 calculable at listing and 392 calculable at listing and at heart transplant. On multivariable analysis, only MELD-XI score (squared) (hazard ratio, 1.007), history of protein-losing enteropathy (hazard ratio, 2.1), and ventricular assist device use at transplant (hazard ratio, 3.4) were risk factors for early phase post-heart transplant mortality. Patients with high MELD-XI scores at heart transplant had inferior survival post-heart transplant (P = .02); those in the high MELD-XI score cohort at wait listing and heart transplant tend to have the worst post-heart transplant survival; however, this was not significant (P = .42). CONCLUSIONS: The MELD-XI, an easily calculated score, serves as a valuable aid in identifying pediatric Fontan patients at increased risk for post-heart transplant mortality.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Amdani S, Simpson KE, Thrush P, et al. Hepatorenal dysfunction assessment with the Model for End-Stage Liver Disease Excluding INR score predicts worse survival after heart transplant in pediatric Fontan patients. J Thorac Cardiovasc Surg. 2021. PMID: 33745714. doi:10.1016/j.jtcvs.2021.02.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。